CAS 910463-68-2

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist primarily used to treat type 2 diabetes and for weight management in obese/overweight adults.

Its core mechanism involves mimicking the GLP-1 hormone, stimulating insulin secretion, lowering blood glucose, and suppressing appetite and delaying gastric emptying to reduce weight.